Tetrafluoroboric acid → HCID 66803128, compound

HRID 1528305Notes

Reaction equation

HRID 1528305 reaction equation
[CH3:1][C:2]1([CH3:12])[CH2:11][NH:10][C@@H:9]2[C@H:4]([CH2:5][CH2:6][CH2:7][CH2:8]2)[NH:3]1.Br[C:14]1[CH:19]=[CH:18][N:17]=[C:16]2[N:20]([Si:23]([CH:30]([CH3:32])[CH3:31])([CH:27]([CH3:29])[CH3:28])[CH:24]([CH3:26])[CH3:25])[CH:21]=[CH:22][C:15]=12.P(C(C)(C)C)(C(C)(C)C)C(C)(C)C.[H+].[B-](F)(F)(F)F.C(O[Na])(C)(C)C>CC([O-])=O.CC([O-])=O.[Pd+2].C1(C)C=CC=CC=1>[CH3:1][C:2]1([CH3:12])[NH:3][C@@H:4]2[C@H:9]([CH2:8][CH2:7][CH2:6][CH2:5]2)[N:10]([C:14]2[CH:19]=[CH:18][N:17]=[C:16]3[N:20]([Si:23]([CH:27]([CH3:29])[CH3:28])([CH:30]([CH3:32])[CH3:31])[CH:24]([CH3:25])[CH3:26])[CH:21]=[CH:22][C:15]=23)[CH2:11]1

Participants

8

Procedure

A toluene (5 mL) suspension of (4aS,8aS)-2,2-dimethyldecahydroquinoxaline (200 mg, 1.19 mmol), 4-bromo-1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine (462 mg, 1.31 mmol), Pd(OAc)2 (13.3 mg, 0.0594 mmol), tBu3P.HBF4 (17.2 mg, 0.0594 mmol), and t-BuONa (137 mg, 1.43 mmol) was stirred at 100° C. for 4 hours in a nitrogen atmosphere. Insoluble matter was filtered through celite, and the filtrate was concentrated. The obtained residue was purified by basic silica gel column chromatography (AcOEt/hexane) to obtain (4aS,8aS)-3,3-dimethyl-1-(1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)decahydroquinoxaline (439 mg, 84%) in a white amorphous solid form.

Workup

  1. filtrationInsoluble matter was filtered through celite
  2. concentrationthe filtrate was concentrated
  3. customThe obtained residue was purified by basic silica gel column chromatography (AcOEt/hexane)

Sources & evidence

ORD record
ord-70de175823ca42398a6a73b0d24502d9
Source dataset
uspto-grants-2015_07
Patent number
US09090572B2

Reaction notes

Loading…